Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature

J Am Acad Dermatol. 2005 Feb;52(2):316-40. doi: 10.1016/j.jaad.2004.07.043.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Age Factors
  • Autoimmune Diseases / drug therapy
  • Child
  • Child, Preschool
  • Cyclosporine / administration & dosage
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Disease Susceptibility
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Infections / etiology
  • Lymphoma / chemically induced
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Rheumatic Diseases / drug therapy*
  • Skin Diseases / drug therapy*

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Cyclosporine
  • Etanercept
  • Methotrexate